Hemcheck Sweden AB has received a follow-up order from its UK distributor, CLS. The order concerns instruments for diagnostic use and bgs-Tests and is of smaller economic value.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.16 SEK | +5.96% | -1.84% | -32.77% |
02-14 | Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-14 | Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-32.77% | 4.15M | |
-6.26% | 12.23B | |
-3.93% | 8.17B | |
+7.10% | 5.78B | |
+30.53% | 5.74B | |
-7.47% | 4.24B | |
-56.63% | 2.97B | |
+12.56% | 2.73B | |
-4.67% | 2.38B | |
+27.88% | 2.26B |
- Stock Market
- Equities
- BIOVIT Stock
- News Bio Vitos Pharma AB
- Hemcheck Sweden AB Receives Follow-Up Order from CLS